BETA: Please send your feedback!
Wound Management Technologies
WNDM:OTC
Pharmaceuticals: Generic
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Pharmaceuticals: Generic
Founded 1982
Wound Management Technologies, Inc. is a commercial stage company with primary products in the wound care market. It focuses on the distribution of patented collagen product, CellerateRX, which is FDA cleared and reimbursable under medicare part B. It expanded its CellerateRX product line to include CellerateRX surgical products. The company was founded by Scott A. Haire in 1982 and is headquartered in Dallas, TX.
website
Headquarters
Executives
Name | Title | Gender |
Scott A. Haire | Founder | Male |
John C. Siedhoff | Chairman | Male |
Deborah Jenkins Hutchinson | President | Female |
Barry E. Constantine | Director-Research & Development | Male |
Alec O. Hochstein, PhD | Medical Director | Male |
J. Michael Carmena | CFO & Principal Accounting Officer | Male |
Mindful Investing Summary
Wound Management Technologies - Competitors and Related Companies
How Wound Management Technologies stacks up to its peers in the Pharmaceuticals: Generic industry or with competing business segments.
Wound Management Technologies
WNDM:OTC
Pharmaceuticals: Generic
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Loading…